ClearPoint Neuro (CLPT) Fundamental Analysis: Revenue, Earnings & Valuation

0.95 / 10

Underperform

Fundamental analysis rates CLPT as Underperform with a 0.9/10 score. Profit‑MV and Cash‑UP are modest positives, while Cash‑MV, ROA and other profitability ratios are negative, suggesting a defensive positioning and limited upside potential.

Analysis Checks(3/10)

ROA (%)

Value-37.30

Score0/3

Weight18.18%

1M Return-6.12%

Annualized return on equity (%)

Value-95.64

Score1/3

Weight8.24%

1M Return-2.02%

Profit-MV

Value0.68

Score2/3

Weight-16.62%

1M Return3.26%

Cash-UP

Value-0.16

Score2/3

Weight15.16%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-37.30

Score0/3

Weight18.18%

1M Return-6.12%

ROE (diluted) (%)

Value-91.15

Score0/3

Weight18.26%

1M Return-5.82%

Asset-MV

Value-0.55

Score0/3

Weight13.32%

1M Return-3.34%

ROE (%)

Value-95.64

Score1/3

Weight8.24%

1M Return-2.02%

Cash-MV

Value0.03

Score1/3

Weight13.07%

1M Return-3.56%

Net profit / Total profit (%)

Value100.22

Score2/3

Weight3.97%

1M Return-0.89%

Is CLPT fundamentally strong?

CLPT scores 0.95/10 on fundamentals and holds a Premium valuation at present. Backed by its -95.64% ROE, -69.08% net margin, -10.91 P/E ratio, 9.94 P/B ratio, and -28.57% earnings growth, these metrics solidify its Underperform investment rating.